The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Compared with bronchodilator-only relievers, "high certainty" evidence showed that ICS-formoterol was associated with an absolute 10.3% lower risk of severe exacerbations (RR 0.65, 95% CI 0.60-0. ...

Now, there is a new minimally invasive procedure to improve lung function that is helping these patients breathe a little easier. Traditionally COPD is treated with bronchodilator medications and ...